Barclays

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
9,146
Total Value
175908309
Accession Number
0000312069-25-000408
Form Type
13F-HR
Manager Name
Barclays
Data Enrichment
89% identified
8,179 identified967 unidentified

Holdings

9,146 positions • $175.9M total value
Manager:
Search and click to pin securities to the top
Page 134 of 226
SMARTFINANCIAL INC.
Shares:20.4K
Value:$635.0K
% of Portfolio:0.4% ($635.0K/$175.9M)
BAYTEX ENERGY CORP.
Shares:284.2K
Value:$633.0K
% of Portfolio:0.4% ($633.0K/$175.9M)
BayCom Corp
Shares:25.1K
Value:$632.0K
% of Portfolio:0.4% ($632.0K/$175.9M)
El Pollo Loco Holdings, Inc.
Shares:61.4K
Value:$632.0K
% of Portfolio:0.4% ($632.0K/$175.9M)
Rapport Therapeutics, Inc.
Shares:62.7K
Value:$629.0K
% of Portfolio:0.4% ($629.0K/$175.9M)
Orchid Island Capital, Inc.
Shares:83.5K
Value:$628.0K
% of Portfolio:0.4% ($628.0K/$175.9M)
LENZ Therapeutics, Inc.
Shares:24.4K
Value:$627.0K
% of Portfolio:0.4% ($627.0K/$175.9M)
Aveanna Healthcare Holdings, Inc.
Shares:115.5K
Value:$626.0K
% of Portfolio:0.4% ($626.0K/$175.9M)
JinkoSolar Holding Co., Ltd.
Shares:33.5K
Value:$625.0K
% of Portfolio:0.4% ($625.0K/$175.9M)
ON24 INC.
Shares:119.9K
Value:$623.0K
% of Portfolio:0.4% ($623.0K/$175.9M)
DOMO, INC.
Shares:80.1K
Value:$622.0K
% of Portfolio:0.4% ($622.0K/$175.9M)
CALAVO GROWERS INC
Shares:25.9K
Value:$622.0K
% of Portfolio:0.4% ($622.0K/$175.9M)
46138E354
Shares:8.3K
Value:$620.0K
% of Portfolio:0.4% ($620.0K/$175.9M)
GoodRx Holdings, Inc.
Shares:140.1K
Value:$618.0K
% of Portfolio:0.4% ($618.0K/$175.9M)
Travere Therapeutics, Inc.
Shares:34.4K
Value:$616.0K
% of Portfolio:0.4% ($616.0K/$175.9M)
DIVERSIFIED HEALTHCARE TRUST
Shares:255.6K
Value:$614.0K
% of Portfolio:0.3% ($614.0K/$175.9M)
URBAN ONE, INC.
Shares:851.2K
Value:$613.0K
% of Portfolio:0.3% ($613.0K/$175.9M)
Cytek Biosciences, Inc.
Shares:152.9K
Value:$613.0K
% of Portfolio:0.3% ($613.0K/$175.9M)
DAKTRONICS INC /SD/
Shares:50.3K
Value:$612.0K
% of Portfolio:0.3% ($612.0K/$175.9M)
Keros Therapeutics, Inc.
Shares:59.9K
Value:$611.0K
% of Portfolio:0.3% ($611.0K/$175.9M)